UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1943-01-01
- Employees
- 8.1K
- Market Cap
- -
A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
Not Applicable
Completed
- Conditions
- Bipolar DisorderCocaine DependenceMethamphetamine Dependence
- Interventions
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2008-01-04
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 96
- Registration Number
- NCT00227123
- Locations
- ๐บ๐ธ
Universty of North Texas Health Science Center, Fort Worth, Texas, United States
๐บ๐ธUniversity of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
Impact of Caregiver Depression on Asthma in the Child
Completed
- Conditions
- AsthmaDepressive Disorder, Major
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-08-03
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 175
- Registration Number
- NCT00223288
- Locations
- ๐บ๐ธ
The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients
Phase 4
Completed
- Conditions
- Memory Impairment Due to Corticosteroid UseHippocampal Atrophy Due to CorticosteroidHypomania Due to Corticosteroid Use
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT00223262
- Locations
- ๐บ๐ธ
The UT Southwestern Medical Center, Dallas, Texas, United States
Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 115
- Registration Number
- NCT00223249
- Locations
- ๐บ๐ธ
The UT Southwestern Medical Center at Dallas, Dallas, Texas, United States
Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study
Phase 4
Completed
- Conditions
- Memory Loss Associated With Corticosteroid UseManic State Associated With Corticosteroid Use
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-08-03
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00223223
- Locations
- ๐บ๐ธ
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
An Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Cocaine Dependence
Phase 4
Completed
- Conditions
- Cocaine DependenceBipolar Disorder
- Interventions
- Drug: PLacebo
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2012-08-20
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00223210
- Locations
- ๐บ๐ธ
The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse
Phase 4
Completed
- Conditions
- Bipolar DisorderMajor Depressive DisorderSubstance Abuse
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2012-04-03
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 75
- Registration Number
- NCT00223197
- Locations
- ๐บ๐ธ
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis
Phase 2
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-04-22
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 24
- Registration Number
- NCT00223301
- Locations
- ๐บ๐ธ
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis
Completed
- Conditions
- Multiple Sclerosis
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2007-01-25
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 1040
- Registration Number
- NCT00223457
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
Naltrexone for Bipolar Disorder and Alcohol Dependence
Phase 4
Completed
- Conditions
- Alcohol DependenceBipolar Disorder
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-05-24
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00223275
- Locations
- ๐บ๐ธ
UTSouthwestern Medical Center, Dallas, Texas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath